Home > Journals > Minerva Endocrinologica > Past Issues > Articles online first > Minerva Endocrinologica 2020 Jun 16



To subscribe
Submit an article
Recommend to your librarian


Publication history
Cite this article as



Minerva Endocrinologica 2020 Jun 16

DOI: 10.23736/S0391-1977.20.03216-2


language: English

COVID-19: The Endocrine opportunity in a pandemic

Subhankar CHATTERJEE 1 , Ritwik GHOSH 2, Payel BISWAS 3, Souvik DUBEY 4, Rishi T. GURIA 1, Chandra B. SHARMA 1, Sanjay KALRA 5

1 Department of General Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India; 2 Department of General Medicine, Burdwan Medical College and Hospital, Burdwan, West Bengal, India; 3 Department of Radiodiagnosis, Care & Cure Hospital, Barasat, West Bengal, India; 4 Department of Neuromedicine, Bangur Institute of Neurosciences, Institute of Post Graduate Medical Education and Research & SSKM Hospital, Kolkata, West Bengal, India; 5 Department of Endocrinology, Bharti Hospital, Karnal, Haryana, India


The 2019 Coronavirus disease (COVID-19) pandemic has disrupted the social, economical and medical system worldwide. Although it is strictly an infectious disease, its intricate bidirectional relationship with various non-communicable metabolic diseases and endocrinological factors has been observed. While diabetes, hypertension, obesity have been found to be independent risk factors for COVID-19 disease severity and mortality, more inclination towards sedentary lifestyle, psychosocial stress at this critical time may be the harbingers of metabolic syndrome. Thus, endocrinologists have a great opportunity to play their role to combat this pandemic. This paper examines how various endocrinological disorders influence the dynamics of COVID-19 and vice versa. Moreover, it also intends to review the clinical guidelines to be adopted in practice of endocrinology in this trying time.

KEY WORDS: COVID-19; SARS-CoV-2; Coronavirus; Endocrinology; Endocrine; Hormone; Corticosteroid; Diabetes; Thyroid; Thymus; Obesity; Metabolic; Parathyroid; Vitamin D; ACE2; Mortality; Ageing; Gender difference; Androgen; Telemedicine; Drug repurposing

top of page